Advertisement
Screener

OptimizeRx Corporation (OPRX) Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect

3.1 / 5 stars · 53/86 Roast Me

OptimizeRx Corporation Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect

OptimizeRx Corporation (OPRX) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$472.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.

Financial Statements › Cash Flow › Change in Cash

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2025-03-20

  • OptimizeRx Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $1.32M.
  • OptimizeRx Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$1.77M.
  • OptimizeRx Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$472.00K.
  • OptimizeRx Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$4.36M.
Period endCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month
2024-12-31-$472.00K
10-K · filed 2025-03-20
2024-09-30$2.27M
10-Q · filed 2024-11-14
2024-06-30$1.11M
10-Q · filed 2024-08-15
2024-03-31$1.32M
10-Q · filed 2024-05-15
2023-12-31-$4.36M
10-K · filed 2025-03-20
2023-09-30-$8.29M
10-Q · filed 2024-11-14
2023-06-30-$8.40M
10-Q · filed 2024-08-15
2023-03-31-$1.77M
10-Q · filed 2024-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
TEN Holdings, Inc. (XHLD)United States$0.152B
Future FinTech Group Inc. (FTFT)$0.144B
Datavault AI Inc. (DVLT)United States$0.144B-1.77
RESOURCES CONNECTION, INC. (RGP)United States$0.129B-3.84
DHI GROUP, INC. (DHX)United States$0.205B132.15
COMSCORE, INC. (SCOR)United States$0.073B-6.35
Research Solutions, Inc. (RSSS)United States$0.071B27.67
Getty Images Holdings, Inc. (GETY)United States$0.068B-2.33
FiscalNote Holdings, Inc. (NOTE)United States$0.065B
Bridger Aerospace Group Holdings, Inc. (BAER)United States$0.049B-9.14